Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Rocket Pharmaceuticals Inc shares valued at $69,109 were sold by Schwartz Jonathan David on Feb 25 ’25. At $10.58 per share, Schwartz Jonathan David sold 6,532 shares. The insider’s holdings dropped to 237,638 shares worth approximately $1.87 million following the completion of this transaction.
Also, Schwartz Jonathan David sold 2,754 shares, netting a total of over 64,306 in proceeds. Following the sale of shares at $23.35 each, the insider now holds 169,659 shares.
Before that, Schwartz Jonathan David had sold 2,710 shares from its account. In a trade valued at $50,135, the insider traded Rocket Pharmaceuticals Inc shares for $18.50 each. Upon closing the transaction, the insider’s holdings decreased to 2,710 shares, worth approximately $1.32 million.
As published in their initiating research note from BMO Capital Markets on March 12, 2025, Rocket Pharmaceuticals Inc [RCKT] has been an Outperform and the price target has been revised to $50. Analysts at Wedbush started covering the stock with ‘”an Outperform”‘ outlook in a report released in late December. As of December 18, 2024, Jefferies has initiated its “Buy” rating for RCKT. Earlier on October 16, 2024, Scotiabank initiated its rating. Their recommendation was “a Sector outperform” for RCKT stock.
Analyzing RCKT Stock Performance
During the last five days, there has been a drop of approximately -5.29%. Over the course of the year, Rocket Pharmaceuticals Inc shares have dropped approximately -37.31%. Shares of the company reached a 52-week high of $13.35 on 01/02/25 and a 52-week low of $7.64 on 03/27/25. A 50-day SMA is recorded $9.69, while a 200-day SMA reached $15.81.
Support And Resistance Levels for Rocket Pharmaceuticals Inc (RCKT)
According to the 24-hour chart, there is a support level at 7.69, which, if violated, would cause prices to drop to 7.49. In the upper region, resistance lies at 8.03. The next price resistance is at 8.17. RSI (Relative Strength Index) is 36.61 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.50, which suggests the price will decrease in the coming days. Percent R is at 81.03%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
